These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18229331)

  • 21. ASSOCIATION OF DIABETES, HYPERSPLENISM, ATROPHIC GASTRITIS AND THYROTOXICOSIS.
    FERRIMAN D
    Proc R Soc Med; 1965 Aug; 58(8):579-80. PubMed ID: 14341830
    [No Abstract]   [Full Text] [Related]  

  • 22. Platelet activation in the presence of neutral protamine Hagedorn insulin: a new feature of antibodies against protamine/heparin complexes.
    Zöllner H; Jouni R; Panzer S; Khadour A; Janzen L; Wesche J; Ten Berg M; Schellong S; Heinken A; Greinacher A; Bakchoul T
    J Thromb Haemost; 2017 Jan; 15(1):176-184. PubMed ID: 27759896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Single daily injection of a mixture of three insulins (regular insulin, protamine-zinc insulin and NPH insulin) in the therapy of insulin-unstable and insulin-resistant diabetes mellitus].
    BOULET P; MIROUZE J; FRUTEAU DE LACLOS C
    Presse Med (1893); 1953 Nov; 61(70):1428-30. PubMed ID: 13120749
    [No Abstract]   [Full Text] [Related]  

  • 24. Protamine-induced fatal anaphylaxis. Prevalence of antiprotamine immunoglobulin E antibody.
    Sharath MD; Metzger WJ; Richerson HB; Scupham RK; Meng RL; Ginsberg BH; Weiler JM
    J Thorac Cardiovasc Surg; 1985 Jul; 90(1):86-90. PubMed ID: 3892171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Implantation of protamine zinc insulin in diabetes in children and adolescents; preliminary communication].
    WINTER A; VARGAS L; LEWIN J
    Rev Chil Pediatr; 1951 Aug; 22(8):319-22. PubMed ID: 14892339
    [No Abstract]   [Full Text] [Related]  

  • 26. Protamine edema in diabetes mellitus; preliminary report.
    ANT M
    N Y State J Med; 1949 Jun; 49(11):1306. PubMed ID: 18128719
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of the use of protamine zinc insulin in two daily injections in some cases of grave diabetes].
    MULLER B; BOUTEILLE H; BOUCHER M
    Arch Mal Appar Dig Mal Nutr; 1953 Apr; 42(4):584-90. PubMed ID: 13093105
    [No Abstract]   [Full Text] [Related]  

  • 28. [NPH insulin (a new modified form of protamine zinc insulin)].
    SCAPELLATO L
    Policlinico Prat; 1953 Aug; 60(33):1137-43. PubMed ID: 13100098
    [No Abstract]   [Full Text] [Related]  

  • 29. Association of protamine IgE and IgG antibodies with life-threatening reactions to intravenous protamine.
    Weiss ME; Nyhan D; Peng ZK; Horrow JC; Lowenstein E; Hirshman C; Adkinson NF
    N Engl J Med; 1989 Apr; 320(14):886-92. PubMed ID: 2648147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Subcutaneous implantation of protamine zinc insulin in human diabetics; critical analysis of obtained results].
    VARGAS L
    Sem Med; 1954; 31(Anniversary Ed):175-80. PubMed ID: 14385930
    [No Abstract]   [Full Text] [Related]  

  • 31. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin.
    Blanco C; Castillo R; Quiralte J; Delgado J; García I; de Pablos P; Carrillo T
    Allergy; 1996 Jun; 51(6):421-4. PubMed ID: 8837667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HYPOGLYCEMIA IN JUVENILE DIABETES.
    ETZWILER DD
    Minn Med; 1963 Nov; 46():1110-5. PubMed ID: 14082177
    [No Abstract]   [Full Text] [Related]  

  • 33. [EXPERIMENTS ON ALTERATION OF THE SITE OF CALCIUM DEPOSITS IN THE RAT KIDNEY BY ALLOXAN DIABETES AND BY GLUCOSE AND INSULIN ADMINISTRATION].
    BEKEMEIER H
    Acta Biol Med Ger; 1965; 14():436-9. PubMed ID: 14315576
    [No Abstract]   [Full Text] [Related]  

  • 34. Adverse reactions to protamine sulfate during cardiac surgery in diabetic and non-diabetic patients.
    Gottschlich GM; Gravlee GP; Georgitis JW
    Ann Allergy; 1988 Oct; 61(4):277-81. PubMed ID: 3177970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetes.
    Levy JH; Zaidan JR; Faraj B
    Anesth Analg; 1986 Jul; 65(7):739-42. PubMed ID: 2424341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-glucagon antibodies in diabetes mellitus.
    Gergely A; Korányl L; Halmos T; Zsombók M; Péterfy F; Csizér F; Salamon F; Takó J
    Ann Immunol Hung; 1973; 17():231-3. PubMed ID: 4808018
    [No Abstract]   [Full Text] [Related]  

  • 37. Allergic shock and death associated with protamine administration in a diabetic patient.
    Chu YQ; Cai LJ; Jiang DC; Jia D; Yan SY; Wang YQ
    Clin Ther; 2010 Sep; 32(10):1729-32. PubMed ID: 21194595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of patients at risk for protamine reactions.
    Levy JH; Schwieger IM; Zaidan JR; Faraj BA; Weintraub WS
    J Thorac Cardiovasc Surg; 1989 Aug; 98(2):200-4. PubMed ID: 2755152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Protamine allergy and cardiac surgery].
    Hynynen M; Kuitunen A
    Duodecim; 1995; 111(20):1969-70. PubMed ID: 9841151
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immediate protamine sulphate allergy in an insulin-treated diabetic patient].
    Petäys T; Kiistala R; Mäkinen-Kiljunen S
    Duodecim; 1999; 115(5):517-20. PubMed ID: 11830901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.